stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Aprea Therapeutics IncAPRE
$0.40660.07%0.0003

Aprea Therapeutics Inc (APRE)

Aprea Therapeutics Inc Stock (APRE) Forecast

The Aprea Therapeutics Inc (APRE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $8.83, representing a +2,073% increase from the current price of $0.4066. The highest analyst price target is $7.98, and the lowest is $9.69.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month APRE Price Target
Average 34.96 (+8,499% Upside)

Is Aprea Therapeutics Inc (APRE) A Buy Now?

Oscillators
NameValueAction
RSI(14)30.76Neutral
STOCH(9,6)9.11Buy
STOCHRSI(14)0.58Buy
MACD(12,26)-0.05Sell
ADX(14)31.10Sell
William %R-88.93Buy
CCI(14)-123.89Sell
Buy: 3 · Sell: 3 · Neutral: 1Summary: Neutral
Moving Averages
PeriodSimpleExponential
MA10
0.46
Sell
0.45
Sell
MA20
0.48
Sell
0.49
Sell
MA50
0.61
Sell
0.57
Sell
MA100
0.66
Sell
0.65
Sell
MA200
0.73
Sell
0.79
Sell
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, APRE could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 13 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on APRE, as trading bearish markets can be challenging and may result in losses.

  1. RSI (Relative Strength Index): The RSI(14) value of 30.76 indicates that APRE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 9.11 indicates that APRE is oversold. This indicates that APRE price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0.58 indicates that APRE is oversold. This suggests that APRE price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of 31.10 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of -123.89 indicates that APRE is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term APRE price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Aprea Therapeutics Inc financial reports and earnings history, Aprea Therapeutics Inc (APRE) stock could reach $35.38 by 2030, $174.99 by 2040 and $372.53 by 2050. See the projected annual prices until 2050 of the Aprea Therapeutics Inc stock below:

  • Aprea Therapeutics Inc (APRE) is expected to reach an average price of $64.98 in 2035, with a high prediction of $93.02 and a low estimate of $65.48. This indicates an +15,880% change from the last recorded price of $0.4066.
  • Aprea Therapeutics Inc (APRE) stock is projected to chart a bullish course in 2040, with an average price target of $127.37, representing an +31,226% change from its current level. The forecast ranges from a conservative $127.62 to a sky-high $174.99.
  • Our analysts predict Aprea Therapeutics Inc (APRE) to change +52,527% by 2045, soaring from $214.13 to an average price of $213.98, potentially reaching $269.19. While $214.13 is the low estimate, the potential upside is significant.
  • Aprea Therapeutics Inc (APRE) stock is expected to climb by 2050, reaching an average of $317.57, a +78,004% change from its current level. However, a wide range of estimates exists, with high and low targets of $372.53 and $317.77, respectively, highlighting the market's uncertainty.

Aprea Therapeutics Inc Stock (APRE) Year by Year Forecast

Aprea Therapeutics Inc Stock (APRE) Price Forecast for 2026

The predicted value for Aprea Therapeutics Inc (APRE) in 2026 is set at an average of $2.57. Estimates vary from a peak of $7.98 to a trough of $0.4, indicating an +532.22% surge from the present price of $0.4066.

MonthAverageLowHighChange from today's price
December, 2026$19.32$9.69$7.98+4,652%

Aprea Therapeutics Inc Stock (APRE) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Aprea Therapeutics Inc (APRE) is $51.78, with a high forecast of $60.24 and a low forecast of $21.83. This indicates an +12,634% increase from the last price of $0.4066.

MonthAverageLowHighChange from today's price
January, 2027$31.75$21.83$25.55+7,708%
February, 2027$42.57$38.70$40.86+10,370%
March, 2027$50.10$46.07$46.69+12,221%
April, 2027$43.52$46.42$43.37+10,604%
May, 2027$50.05$44.03$46.55+12,209%
June, 2027$61.67$53.56$60.24+15,068%
July, 2027$60.90$61.76$60.18+14,877%
August, 2027$53.03$58.96$60.01+12,941%
September, 2027$55.25$55.85$54.54+13,488%
October, 2027$57.47$57.15$57.07+14,035%
November, 2027$58.00$57.99$56.98+14,164%
December, 2027$57.03$57.22$56.15+13,925%

Aprea Therapeutics Inc Stock (APRE) Price Forecast for 2028

In 2028, Aprea Therapeutics Inc (APRE) is projected to reach an average price of $56.57, with a high projection of $61.45 and a low estimate of $51.16. This indicates an +13,813% rise from the last price of $0.4066.

MonthAverageLowHighChange from today's price
January, 2028$60.65$57.13$61.45+14,817%
February, 2028$60.36$59.59$59.61+14,745%
March, 2028$56.80$57.40$60.06+13,870%
April, 2028$55.94$55.92$56.31+13,659%
May, 2028$58.91$58.25$59.30+14,389%
June, 2028$58.36$58.63$58.31+14,252%
July, 2028$57.35$57.49$57.95+14,006%
August, 2028$56.52$56.70$57.03+13,800%
September, 2028$55.80$56.14$56.04+13,624%
October, 2028$54.38$54.45$55.40+13,274%
November, 2028$52.66$52.85$53.09+12,852%
December, 2028$51.13$51.16$52.22+12,474%

Aprea Therapeutics Inc Stock (APRE) Price Forecast for 2029

The 2029 price forecast for Aprea Therapeutics Inc Stock (APRE) is $41.69 on average, with a high prediction of $50.33 and a low estimate of $36.33. This represents an +10,153% increase from the previous price of $0.4066.

MonthAverageLowHighChange from today's price
January, 2029$49.58$49.33$50.33+12,093%
February, 2029$48.64$48.65$49.42+11,862%
March, 2029$47.62$47.72$47.93+11,611%
April, 2029$44.25$44.89$46.79+10,783%
May, 2029$42.93$43.71$43.49+10,459%
June, 2029$39.02$40.65$41.44+9,496%
July, 2029$39.32$39.46$39.42+9,569%
August, 2029$39.63$39.71$39.12+9,646%
September, 2029$38.38$38.40$39.28+9,340%
October, 2029$38.17$38.27$37.94+9,288%
November, 2029$37.00$37.08$37.56+9,001%
December, 2029$35.73$36.33$36.61+8,688%

Aprea Therapeutics Inc Stock (APRE) Price Forecast for 2030

Aprea Therapeutics Inc Stock (APRE) is expected to reach an average price of $28.78 in 2030, with a high forecast of $35.38 and a low forecast of $22.59. This signifies an +6,977% surge from the last price of $0.4066.

MonthAverageLowHighChange from today's price
January, 2030$35.21$35.33$35.38+8,559%
February, 2030$34.58$34.64$34.80+8,405%
March, 2030$32.09$32.18$34.12+7,793%
April, 2030$31.63$31.82$31.56+7,680%
May, 2030$29.98$30.61$30.44+7,275%
June, 2030$28.33$28.84$29.58+6,867%
July, 2030$28.09$27.59$27.42+6,808%
August, 2030$27.14$27.23$27.50+6,575%
September, 2030$26.56$26.58$26.82+6,432%
October, 2030$25.26$25.30$26.08+6,113%
November, 2030$23.96$23.97$24.58+5,792%
December, 2030$22.49$22.59$23.43+5,432%

Similar to APRE